PhaseBio Pharmaceuticals, Inc. (PHAS)
Total Non-Current Liabilities
$114.89M
Quarterly · Period ending: · USD
PHAS Total Non-Current Liabilities
Latest reported$125.69Mperiod ending
Latest reported$125.69Mperiod ending
PHAS FY Total Non-Current Liabilities ($90.46M → $125.69M)
Annual total non-current liabilities
High-resolution chart · PNG
PHAS total non-current liabilities history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Total Non-Current Liabilities (USD) |
|---|---|
| 125,691,000 | |
| 60,599,000 | |
| 14,037,000 | |
| 7,522,000 | |
| 93,920,000 | |
| 90,455,000 |